Hsue, Priscilla |
| Withdrawn | 3 | 550 | US | Baricitinib 4 MG, Olumiant, Placebo | Vanderbilt University Medical Center, Emory University, University of California, San Francisco, University of Minnesota, Vanderbilt University, Yale University | Post-Acute COVID-19 Syndrome | 12/27 | 12/29 | | |
| Recruiting | 3 | 140 | US | Alirocumab, Sar236553/REG727, Placebo | University of California, San Francisco, Massachusetts General Hospital | Dyslipidemias, Cardiovascular Diseases, HIV Infections | 07/24 | 07/25 | | |
NCT02272946: Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk |
|
|
| Completed | 2 | 43 | US | Canakinumab, IL--1β, Placebo | Priscilla Hsue, MD, Massachusetts General Hospital | HIV, Cardiovascular Disease | 02/21 | 12/21 | | |
| Active, not recruiting | 2 | 40 | US | Ensitrelvir, ensitrelvir fumaric acid, Placebo | Timothy Henrich, Shionogi Inc. | Long COVID, Post Acute Sequelae of COVID-19, Post-Acute COVID-19 | 06/25 | 12/25 | | |
NCT06029712: Heart Failure Polypill at a Safety Net Hospital |
|
|
| Active, not recruiting | 2 | 35 | US | Heart failure polypill, Control Rx | University of California, San Francisco, UCSF CAPS-HIV Innovative Grant, UCSF CFAR-ARI HIV Boost Award, ACC/ABC Merck Research Fellowship Award (support for Dr. DeJong) | Heart Failure With Reduced Ejection Fraction, HIV Infections | 09/24 | 12/24 | | |
| Active, not recruiting | 2 | 36 | US | AER002, Placebo | Michael Peluso, MD, Aerium Therapeutics, Patient-Led Research Collaborative, PolyBio Research Foundation | Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 | 07/24 | 07/25 | | |
CLEAR HIV, NCT05488431: Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial ( Trial) |
|
|
| Recruiting | 2 | 121 | US | Bempedoic acid, BA, Placebo | Priscilla Hsue, MD, University of California, Los Angeles, Massachusetts General Hospital | Dyslipidemias, Cardiovascular Diseases, HIV Infections, Atherosclerosis | 03/28 | 03/28 | | |
Chao, Maria |
| Completed | N/A | 44 | US | group acupuncture, Integrative Group Medical Visits | University of California, San Francisco, National Institute on Minority Health and Health Disparities (NIMHD) | Chronic Pain | 12/23 | 12/23 | | |
| Recruiting | N/A | 360 | US | Group Acupuncture, Integrative Group Medical Visits | University of California, San Francisco, National Institute on Minority Health and Health Disparities (NIMHD) | Chronic Pain | 04/27 | 04/27 | | |
NCT06633926: Integrative Approaches for Cancer Survivorship (IACS3) |
|
|
| Not yet recruiting | N/A | 104 | US | Nutrition Education, Lifestyle Counseling, Yoga, Yoga therapy, Marma therapy, Marma therapeutic touch therapy, Therapeutic touch therapy, Educational Intervention, Education for Intervention, Quality of Life Questionnaire Administration, Quality of Life Survey | University of California, San Francisco, National Center for Complementary and Integrative Health (NCCIH) | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 12/26 | 06/27 | | |
Sharon, Jeffrey D |
| Completed | 2 | 40 | US | Galcanezumab Prefilled Syringe, Emgality, Placebo | University of California, San Francisco, Eli Lilly and Company | Vestibular Migraine | 09/23 | 09/23 | | |
Leutkemeyer, Annie |
NCT04340596: Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption |
|
|
| Recruiting | 1 | 46 | US | N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074 | National Institute of Allergy and Infectious Diseases (NIAID), Rockefeller University, ImmunityBio, Inc. | HIV Infection | 06/26 | 12/26 | | |
Chang, Odmara Barreto |
| Completed | N/A | 22 | US | Extended translation, Standard translation | University of California, San Francisco, Mount Zion Health Fund | Limited English Proficiency, Perioperative Care | 06/23 | 06/23 | | |
| Recruiting | N/A | 30 | US | | University of California, San Francisco, National Institute on Aging (NIA) | Mild Cognitive Impairment, Delirium | 12/23 | 12/23 | | |
Vu, Thanh-Giang |
| Completed | N/A | 22 | US | Extended translation, Standard translation | University of California, San Francisco, Mount Zion Health Fund | Limited English Proficiency, Perioperative Care | 06/23 | 06/23 | | |